Subscriber login

Welcome to our new site. You will need to reset your password if this is your first time logging in. Please click here to reset your password.
Business
What you need to know for 01/21/2017

D'Ambra retiring as Albany Molecular Research chief

D'Ambra retiring as Albany Molecular Research chief

Thomas E. D'Ambra will retire as president and chief executive officer of Albany Molecular Research

Thomas E. D'Ambra, founder of Albany Molecular Research (AMRI), will retire as president and chief executive officer of the firm at year's end, the company announced this morning.

William S. Marth, now non-executive chairman of the company's board, will succeed D'Ambra.

D'Ambra will remain with the firm as the non-executive chairman of the board of directors.

Marth joined AMRI as a member of the board of directors in June 2012. He was formerly president and chief executive officer of Teva Americas, a specialty pharmaceutical company.

AMRI, founded in 1991, is a research and manufacturing organization that focuses on drug discovery and development projects.

View Comments
Hide Comments
You have 0 articles 1 articles 2 articles 3 articles 4 articles 5 articles 6 articles 7 articles remaining of Daily Gazette free premium content.

You have reached your monthly premium content limit.

Continue to enjoy Daily Gazette premium content by becoming a subscriber.
Already a subscriber? Log In